Covid-19 man­u­fac­tur­ing roundup: 9 part­ners to help Bio­vac's man­u­fac­tur­ing ex­pan­sion; Af­ter pro­duc­tion pledges, Covid-19 test de­mand has plum­met­ed

A con­sor­tium of nine part­ners will sup­port Bio­vac’s ex­pan­sion of its South African man­u­fac­tur­ing plant ca­pac­i­ty in an ef­fort to boost pro­duc­tion of the Pfiz­er-BioN­Tech Covid-19 vac­cine.

Bio­vac will raise about $150 mil­lion to boost lo­cal ca­pac­i­ty, in an ef­fort to get dos­es across Africa. Part­ners in­clude the African De­vel­op­ment Bank (AfDB), CDC Group, Ger­man fi­nan­cial group DEG, the US In­ter­na­tion­al De­vel­op­ment Fi­nance Cor­po­ra­tion, and France’s Propar­co.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER